Journal
JOURNAL OF DIABETES RESEARCH
Volume 2013, Issue -, Pages -Publisher
HINDAWI LTD
DOI: 10.1155/2013/940710
Keywords
-
Funding
- Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus)
- Federal Ministry of Education and Research [FKZ 01GI0805-07]
- BMBF [FKZ01GI0924]
- DFG, Center for Regenerative Therapies Dresden, Cluster of Excellence [FZT 111]
Ask authors/readers for more resources
Studies on human type 1 diabetes (T1D) are facilitated by the availability of animal models such as nonobese diabetic (NOD) mice that spontaneously develop autoimmune diabetes, as well as a variety of genetically engineered mouse models with reduced genetic and pathogenic complexity, as compared to the spontaneous NOD model. In recent years, increasing evidence has implicated CD4(+) CD25(+) regulatory T (Treg) cells expressing the transcription factor Foxp3 in both the breakdown of self-tolerance and the restoration of immune homeostasis in T1D. In this paper, we provide an overview of currently available mouse models to study the role of Foxp3(+) Treg cells in the control of destructive beta cell autoimmunity, including a novel NOD model that allows specific and temporally controlled deletion of Foxp3(+) Treg cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available